Quantitative, comprehensive multi-pathway signaling analysis using an optimized phosphopeptide enrichment method combined with an internal standard triggered targeted MS assay

Significance of the topic

Protein phosphorylation is a key post-translational modification controlling signal transduction in health and disease. Quantitative monitoring of dynamic phosphorylation events across multiple pathways informs on cellular responses to stimuli and supports therapeutic target validation. High specificity and sensitivity are required to detect low-abundance phosphopeptides and to resolve site localization and stoichiometry.

Study objectives and overview

This study aimed to develop a robust workflow for comprehensive quantitation of phosphopeptides spanning diverse signaling pathways. By integrating sequential metal oxide affinity chromatography (SMOAC) enrichment, a 146‐peptide AQUA heavy‐isotope standard, and an internal standard‐triggered targeted MS assay (SureQuant), the authors evaluated phosphorylation changes in HeLa and A549 cells following EGF and IGF-1 stimulation.

Methodology

Cell Culture and Treatment:

• HeLa S3 and A549 cells serum‐starved and treated with hEGF or hIGF‐1.

Protein Digestion and Enrichment:

• In‐solution tryptic digestion of 1 mg cell lysate with spike‐in of 100 fmol 146‐peptide standard.
• Sequential enrichment using Pierce HiSelect TiO₂ and Fe-NTA kits (SMOAC).
• C18 cleanup prior to LC‐MS.

LC‐MS Acquisition:

• NanoLC separation on C18 EASY‐Spray column with 120 min gradient.
• Orbitrap Exploris 480 and Eclipse for DDA, DIA, PRM, and SureQuant methods.
• SureQuant workflow: survey run to define heavy peptide triggers followed by high‐resolution MS2 on endogenous targets.

Data Analysis:

• Proteome Discoverer 2.2 and Sequest HT for DDA.
• Skyline for PRM/SureQuant quantitation of light/heavy ratios.

Used instrumentation

• Thermo Scientific Pierce HiSelect TiO₂ and Fe-NTA enrichment kits
• Thermo Scientific EASY‐Spray™ C18 nanoLC column
• Thermo Scientific Dionex UltiMate 3000 RSLCnano and EASY‐nLC 1200 systems
• Thermo Scientific Orbitrap Exploris 480 and Eclipse Tribrid MS
• Thermo Scientific Q Exactive HF MS

Main results and discussion

More than 90% of the 146 heavy‐labeled standards were reproducibly detected. SMOAC enrichment coupled with SureQuant enabled quantitation of ~134 heavy standards and ~60 endogenous phosphopeptides across 80+ signaling proteins. Compared to conventional DDA and DIA, the SureQuant method improved signal‐to‐noise ratio, sensitivity and quantitative precision. Differential phosphorylation patterns between HeLa (EGF) and A549 (IGF) cells highlighted pathway‐specific regulation.

Benefits and practical applications

• Highly multiplexed measurement of phosphorylation in a single run.
• Improved detection of low‐abundance and positional isomers.
• Reproducible quantitation across experiments and instruments.
• Applicable to cell signaling research, biomarker discovery, and drug screening.

Future trends and applications

Advancements may include expansion of the heavy‐peptide library to cover additional PTMs and integration with data‐independent acquisition for deeper coverage. Clinical translation could leverage this targeted workflow for patient stratification and monitoring of pathway modulation by therapies. Automated platforms and microflow LC may increase throughput for large‐scale studies.

Conclusion

The optimized SMOAC enrichment combined with a 146‐peptide heavy standard and SureQuant targeted MS delivers a powerful platform for quantitative, multi‐pathway phosphoproteomic analysis with high sensitivity, specificity, and throughput.

References

• Logue JS, Morrison DK. Complexity in the signaling network: insights from the use of targeted inhibitors in cancer therapy. Genes Dev. 2012 Apr 1;26(7):641-50.